T1	Participants 79 140	after autologous blood stem cell transplantation in children:
T2	Participants 270 408	74 children who were scheduled to undergo high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation (PBSCT)
T3	Participants 1008 1159	11 patients were excluded due to disease progression before PBSCT (n = 6) or a low number of harvested cells (n = 5), leaving 63 patients for analysis;
T4	Participants 1703 1716	Five patients
T5	Participants 3389 3414	children undergoing PBSCT